Article
Genetics of remnant cholesterol
23 Apr 2025
Abstract excerpt
PURPOSE OF REVIEW: Remnant cholesterol is receiving increasing attention as a target to reduce residual atherosclerotic cardiovascular disease (ASCVD) risk in individuals already treated with statins. New therapeutic options as antisense oligonucleotides, small interfering RNA, and monoclonal antibodies allow specific targeting of genes and proteins to counter pathological pathways promoted by these genes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
